1. Home
  2. CNMD vs VIR Comparison

CNMD vs VIR Comparison

Compare CNMD & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CONMED Corporation

CNMD

CONMED Corporation

HOLD

Current Price

$41.65

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$7.54

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNMD
VIR
Founded
1970
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
1987
2019

Fundamental Metrics

Financial Performance
Metric
CNMD
VIR
Price
$41.65
$7.54
Analyst Decision
Hold
Strong Buy
Analyst Count
6
8
Target Price
$51.20
$28.63
AVG Volume (30 Days)
627.5K
1.8M
Earning Date
01-28-2026
02-23-2026
Dividend Yield
1.44%
N/A
EPS Growth
N/A
N/A
EPS
1.51
N/A
Revenue
$1,374,724,000.00
$16,860,000.00
Revenue This Year
$1.84
N/A
Revenue Next Year
$5.21
N/A
P/E Ratio
$27.68
N/A
Revenue Growth
5.18
N/A
52 Week Low
$35.37
$4.16
52 Week High
$65.50
$10.01

Technical Indicators

Market Signals
Indicator
CNMD
VIR
Relative Strength Index (RSI) 56.38 60.06
Support Level $41.06 $7.08
Resistance Level $43.84 $7.67
Average True Range (ATR) 1.86 0.45
MACD 0.34 -0.01
Stochastic Oscillator 83.71 75.75

Price Performance

Historical Comparison
CNMD
VIR

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: